baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BIOTEST AG ST O.N./ DE0005227201 /

06/09/2024 07:57:28	Chg. 0.000	Volume	Bid07:57:28	Ask07:57:28	Market Capitalization	Dividend Y.	P/E Ratio
41.000EUR	0.00%	- Turnover: -	41.000Bid Size: -	42.000Ask Size: -	1.62 bill.EUR	0.10%	-

GlobeNewswire 01/07 Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

GlobeNewswire 17/06 Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...

GlobeNewswire 14/02 Grifols announces positive topline phase 3 fibrinogen clinical trial results

GlobeNewswire 03/12/2021 Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congres...

GlobeNewswire 09/08/2021 ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NA...

GlobeNewswire 13/04/2021 ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Inf...

GlobeNewswire 09/12/2020 ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors

GlobeNewswire 03/03/2020 AB2 Bio Appoints Michael Soldan CEO

GlobeNewswire 10/10/2019 2019 Italian Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares, Vo...

GlobeNewswire 10/10/2019 Canada Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strat...

GlobeNewswire 10/10/2019 United Arab Emirates Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019: Suppli...

GlobeNewswire 10/10/2019 Bahrain Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests, 2019: Infectious and Gen...

GlobeNewswire 10/10/2019 Cyprus Nucleic Acid Testing Market for 100 Assays, 2019: Companies Such as Arca Biopharma, Diadexus ...

GlobeNewswire 10/10/2019 South Korean Nucleic Acid Testing Market for 100 Assays: Five-year test volume and sales forecasts

GlobeNewswire 10/10/2019 2019 Kuwait Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volu...

GlobeNewswire 10/10/2019 Malta Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic ...

GlobeNewswire 23/09/2019 ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference

GlobeNewswire 22/08/2019 ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®

GlobeNewswire 08/08/2019 ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results

GlobeNewswire 08/07/2019 ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®

GlobeNewswire 18/06/2019 Global $12.89 Bn Glucose Monitoring Markets, 2018-2019 & 2019-2025

GlobeNewswire 29/05/2019 ADMA Biologics to Present at Upcoming Investor Conferences

GlobeNewswire 10/05/2019 FDA Approves Prior Approval Supplement for BIVIGAM®

GlobeNewswire 08/05/2019 ADMA Biologics Reports First Quarter 2019 Financial Results

GlobeNewswire 03/05/2019 ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing Perceptive Advisors Credi...

BIOTEST AG ST O.N./ DE0005227201 /

If you wish to receive reply to your feedback, please provide your email address.